- Home
- OMF vs LNTH Comparison
OMF vs LNTH Comparison
Compare OMF & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMF
- LNTH
- Stock Information
- Founded
- OMF 1920
- LNTH 1956
- Country
- OMF United States
- LNTH United States
- Employees
- OMF N/A
- LNTH N/A
- Industry
- OMF Finance: Consumer Services
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OMF Finance
- LNTH Health Care
- Exchange
- OMF Nasdaq
- LNTH Nasdaq
- Market Cap
- OMF 6.3B
- LNTH 7.5B
- IPO Year
- OMF 2013
- LNTH 2015
- Fundamental
- Price
- OMF $54.11
- LNTH $79.19
- Analyst Decision
- OMF Buy
- LNTH Strong Buy
- Analyst Count
- OMF 10
- LNTH 5
- Target Price
- OMF $57.40
- LNTH $133.80
- AVG Volume (30 Days)
- OMF 829.1K
- LNTH 1.0M
- Earning Date
- OMF 07-30-2025
- LNTH 07-30-2025
- Dividend Yield
- OMF 7.69%
- LNTH N/A
- EPS Growth
- OMF N/A
- LNTH N/A
- EPS
- OMF 4.73
- LNTH 3.53
- Revenue
- OMF $2,583,000,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- OMF $74.69
- LNTH $4.63
- Revenue Next Year
- OMF $7.73
- LNTH $9.35
- P/E Ratio
- OMF $11.43
- LNTH $22.44
- Revenue Growth
- OMF 0.94
- LNTH 12.53
- 52 Week Low
- OMF $38.00
- LNTH $73.11
- 52 Week High
- OMF $58.90
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- OMF 60.98
- LNTH 44.57
- Support Level
- OMF $52.27
- LNTH $76.34
- Resistance Level
- OMF $53.35
- LNTH $84.36
- Average True Range (ATR)
- OMF 1.10
- LNTH 2.69
- MACD
- OMF -0.01
- LNTH 0.66
- Stochastic Oscillator
- OMF 91.46
- LNTH 48.07
About OMF OneMain Holdings Inc.
OneMain Holdings Inc is a consumer finance company providing loan products to customers through its branch network and the internet. The company provides personal loan products; offers credit cards; offers optional credit insurance and others; offers a customer-focused financial wellness program, and acquisitions and dispositions of assets and businesses. It provides origination, underwriting, and servicing of personal loans to non-prime customers. The company's reportable segment is Consumer and Insurance. The main source of revenue is net interest income.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.